The relationship between acute phase serum amyloid A (SAA) protein concentrations and left ventricular systolic function in acute myocardial infarction patients treated with primary coronary angioplasty

International Heart Journal

Volumn 48, Issue 1, 2007, Pages 45-55

  Katayama, Toshiro ^a   Nakashima, Hiroshi ^b   Honda, Yukiharu ^b   Suzuki, Shin ^b   Yamamoto, Tadashi ^c   Iwasaki, Yoshihiro ^c   Yano, Katsusuke ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Nagasaki Kouseikai Hospital   (Japan)

Author keywords

Left ventricular function; Myocardial infarction; Serum amyloid A protein

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CREATINE KINASE; SERUM AMYLOID A;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICULOGRAPHY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECANALIZATION; REPERFUSION; SENSITIVITY ANALYSIS; SYSTOLIC DYSFUNCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; FEMALE; GATED BLOOD-POOL IMAGING; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 34047131280     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.45     Document Type: Article

References (27)

1. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001; 88: 10K-5. (Review)
2. Stefanadis C, Diamantopoulos L, Dernellis J, et al. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol 2000; 3: 43-52.
3. Keskin O, Ulusoy RE, Kalemoglu M, et al. White blood cell count and C-reactive protein predict short-term prognosis in acute myocardial infarction. J Int Med Res 2004; 32: 646-54.
4. Veselka J. Prochazkova S, Duchonova R, Homolova I, Tesar D. Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris. Int Heart J 2005; 46: 195-204.
5. Yip HK, Wu CJ, Chang HW, et al. Levels and values of serum high C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest 2004; 126: 1417-22.
6. Sano, T, Tanaka A, Namba M, et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 2003; 108: 282-5.
7. Dibra A, Mehilli J, Schwaiger M, et al. Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. Eur Heart J 2003; 24: 1128-33.
8. Berton G, Cordiano, R, Palmieri R, Pianca S, Pagliara V, Palatini P. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J 2003; 145: 1094-101.
9. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 2005; 46: 801-9.
10. Sanchis J, Bodi V, Llacer A, et al. Usefulness of C-reactive protein anti left ventricular function for risk assessment in survivors of acute myocardial infarction. Am J Cardiol 2004; 94: 766-9.
11. Uehara K, Nomura M, Ozaki Y, et al. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction. Heart Vessels 2003; 18: 67-74.
12. Takahashi T, Anzai T, Yoshikawa T, et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction - role of neurohormones and cytokines. Int J Cardiol 2003; 88: 257-65.
13. Morishima I, Sone T, Tsuboi H, et al. Plasma C-reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: comparison with brain natriuretic peptide. Clin Cardiol 2002; 25: 112-6.
14. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996; 26: 427-35. (Review)
15. Casl MT, Surina B, Glojnaric-Spasic I, Pape E, Jagarinec N, Kranjcevic S. Serum amyloid A protein with acute myocardial infarction. Ann Clin Biochem 1995; 32: 196-200.
16. Katayama T, Nakashima H, Takagi C, et al. Prognostic value of serum amyloid A protein in patients with acute myocardial infarction. Circ J 2005; 69: 1186-91.
17. Sheehan FH, Schofer J, Mathey DG, et al. Measurement of regional wall motion from biplane contrast ventriculograms: a comparison of the 30 degree right anterior oblique and 60 degree left anterior oblique projections in patients with acute myocardial infarction. Circulation 1986; 74: 796-804.
18. Brodie BR, Stuckey TD, Muncy DB, et al. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 2003; 145: 708-15.
19. Sakurai K, Watanabe J, Iwabuchi K, et al. Comparison of the efficacy of reperfusion therapies for earty mortality from acute myocardial infarction in Japan: registry of Miyagi Study Group for AMI (MsAMI. Circ J 2003; 67: 209-14.
20. Watanabe K, Nagao K, Watanabe I, Kanmatsuse K. Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial. Circ J 2004; 68: 280-5.
21. Degeare VS, Dangas G, Stone GW, Grines CL. Interventional procedures in acute myocardial infarction. Am Heart J 2001; 141: 15-24. (Review)
22. Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002; 287: 1943-51.
23. Anzai T, Yoshikawa T, Asakura Y, et al. Effect on short-term prognosis and left ventricular function of angina pectoris prior to first Q-wave anterior wall acute myocardial infarction. Am J Cardiol 1994; 74: 755-9.
24. Katayama T, Nakashima H, Takagi C, et al. Predictors of sub-acute stent thrombosis in acute myocardial infarction patients following primary coronary stenting with bare metal stent. Circ J 2006; 70: 151-5.
25. Katayama T, Nakashima H, Takagi C, et al. Serum amyloid a protein as a predictor of cardiac rupture in acute myocardial infarction patients following primary coronary angioplasty. Circ J 2006; 70: 530-5.
26. Maier W, Altwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005; 111: 1355-61.
27. Pussinen PJ, Malle E, Metso J, Sattler W, Raynes JG, Jauhiainen M. Acute-phase HDL in phospholipids transfer protein (PLTP)-mediated HDL conversion. Atherosclerosis 2001; 155: 297-305.